Clinical Trials Browser

Phase 2 × INDUSTRY × Papillomavirus Vaccines × Clear all

NCT02740790 2023-04-13

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Phase 2 Completed

Uterine Cervical Neoplasms

NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Phase 2 Completed

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

NCT00231413 2019-12-12

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Phase 2 Completed

383 enrolled 30 charts

Papillomavirus Infections

NCT00309166 2018-09-17

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Phase 2 Completed

270 enrolled 14 charts

Papillomavirus Infections

NCT01909752 2017-07-06

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms